Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK134612 vs Menactra in Healthy Subjects 10-25 Years
NCT01165242Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2010
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal infection, sponsored by GSK. Started Aug 2010; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT01165242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165242.